Workshop B: Translating Microbiome Data into Actionable Biomarkers & Regulatory Approvals
Time: 1:00 pm
day: Pre-Conference Workshop Day
Details:
As microbiome-based therapeutics move closer to regulatory pathways, overcoming data variability and establishing robust biomarkers is essential. This workshop will explore:
- Defining and Validating Microbiome Biomarkers: Discover best practices for developing clinically meaningful biomarkers and linking them to regulatory endpoints
- AI and Big Data in Microbiome Research: Learn how AI-driven analytics and spatial biology are shaping the next generation of microbiome-based therapeutics
- Regulatory Considerations for Microbiome Drug Development:
- Navigate the evolving FDA landscape and understand what it will take to translate microbiome biomarkers into approvable clinical endpoints
- Investor and Industry Perspectives: Gain insights from investors and industry leaders on which microbiome innovations hold the greatest potential for commercialization
Join this deep dive into the intersection of microbiome data science, regulatory strategy, and commercialization to accelerate your therapeutic pipeline.
